EGFR and non-small cell lung carcinoma: HCC827 (EGFR mutated non-small-cell lung cancer: NSCLC) and H3122 (ALK+ NSCLC) cells did not respond to the FM, whereas SKBR3 (HER2+ breast cancer), BT474 (HER2+ breast cancer), and HCT116 (colorectal cancer) cells were responsive to it, showing reduced cell viability [29].